Development of a multicomponent vaccine for Streptococcus pyogenes based on the antigenic targets of IVIG

Spy7 vaccination successfully stimulated the generation of protective anti-streptococcal immunity in vivo. Identification of reactive antigens using pooled human immunoglobulin may represent a novel route to vaccine discovery for extracellular bacteria.